comprehensive -WSS

comprehensive

author：knowledge 2025-08-11 08:01:26 - browse：2

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Europe is fastest

hotspot

entertainment

knowledge

WSS

Experts study whether long Covid risk adds up with each reinfection

Europe is fastest

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

What we owe ALS patients — and why one company fell short

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Judge orders hearing on Trump's motion to disqualify Fulton County DA

hotspot

comprehensive

explore

The cancer drug shortage isn’t new — and neither are the solutions

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

The cancer drug shortage isn’t new — and neither are the solutions

Stop Congress from blocking public access to science

Wildfire smoke exposes gaps in outdoor worker protections

The biotech scorecard for Q4: 16 stock

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Jerome Adams on the need for new antivirals for Covid

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

entertainment

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Doctors in states that ban abortion can still help patients

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

New oral drug delivery patch is modeled after octopus tentacles

Medicare innovation center doesn’t save money, experts say

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

hotspot

entertainment

knowledge

explore